About ClinChoice
ClinChoice is a company based in Fort Washington (United States) founded in 1995 by John D Balian and Xin Ke. ClinChoice has raised $212 million across 2 funding rounds from investors including Goldman Sachs, Taikang Insurance Group and Legend Capital. The company has 474 employees as of April 06, 2024. ClinChoice has completed 2 acquisitions, including CROMSOURCE and CSI Medical Research. ClinChoice offers products and services including Clinical Development, Post-Marketing Services, and Regulatory Affairs. ClinChoice operates in a competitive market with competitors including Emmes, Syneos Health, Veristat, Medelis WCCT Global and Celgene, among others.
- Headquarter Fort Washington, United States
- Employees 474 as on 06 Apr, 2024
- Founders John D Balian, Xin Ke
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Clinchoice Private Limited
- Date of Incorporation 20 Apr, 2013
- Jurisdiction Bangalore, Karnataka, India
-
Annual Revenue
$10.3 M (USD)35.19as on Mar 31, 2023
-
Net Profit
$1.22 M (USD)100.61as on Mar 31, 2023
-
EBITDA
$2.05 M (USD)67.34as on Mar 31, 2023
-
Total Equity Funding
$212 M (USD)
in 2 rounds
-
Latest Funding Round
$150 M (USD), Series E
Jul 04, 2022
-
Investors
Goldman Sachs
& 5 more
-
Employee Count
474
as on Apr 06, 2024
-
Investments & Acquisitions
CROMSOURCE
& 1 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of ClinChoice
ClinChoice offers a comprehensive portfolio of products and services, including Clinical Development, Post-Marketing Services, and Regulatory Affairs.
Supports clinical trials and studies for drug development
Manages post-approval studies and evidence collection globally
Assists with regulatory compliance and strategic consulting
People of ClinChoice
Unlock access to complete
Leadership Team
56 people
Software Development Team
37 people
Senior Team
26 people
Data Analysis and Operations Team
20 people
Human Resources and Administration
13 people
Regulatory Team
12 people
Sales and Marketing
11 people
Finance and Accounting
10 people
Unlock access to complete
Funding Insights of ClinChoice
ClinChoice has successfully raised a total of $212M across 2 strategic funding rounds. The most recent funding activity was a Series E round of $150 million completed in July 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in ClinChoice
ClinChoice has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Goldman Sachs, Taikang Insurance Group and Legend Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture Capital firm focused on multiple sectors
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Apricot Capital is engaged in investing in impactful entrepreneurs.
|
Locked | Locked | Locked |
Investor details for ClinChoice
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by ClinChoice
ClinChoice has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include CROMSOURCE and CSI Medical Research.
Investment portfolio details for ClinChoice
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Clinical research services for site management are provided.
|
Locked | Locked | 2017 | Locked | |
|
An ISO-certified CRO and provider of outsourced services to the pharmaceutical, biotechnology and medical device industries
|
Locked | Locked | 1994 | Locked |
Complete acquisition details for ClinChoice
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - ClinChoice
Detailed financials for ClinChoice
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Clinchoice Comparisons
Peer comparison for ClinChoice
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of ClinChoice
ClinChoice operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Emmes, Syneos Health, Veristat, Medelis WCCT Global and Celgene, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Outsourced contract research organization services are provided to clients.
|
|
| Locked | Locked | Locked |
CRO clinical development services are provided by Syneos Health.
|
|
| Locked | Locked | Locked |
Clinical trials and regulatory submissions are supported as a CRO.
|
|
| Locked | Locked | Locked |
Full-service CRO expertise in influenza and oncology research is offered.
|
|
| Locked | Locked | Locked |
Therapies for cancer and inflammatory diseases are developed.
|
Detailed competitors of ClinChoice
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Clinchoice
Complete news archive for ClinChoice
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about ClinChoice
ClinChoice was founded in 1995 and raised its 1st funding round 24 years after it was founded.
ClinChoice is headquartered in Fort Washington, United States. It is registered at Fort Washington, Maryland, United States.
John D Balian is the current CEO of ClinChoice. They have also founded this company.
ClinChoice is a funded company, having raised a total of $212M across 2 funding rounds to date.
As of Apr 06, 2024, the latest employee count at ClinChoice is 474.
Annual revenue of ClinChoice is $10.3M as on Mar 31, 2023.
ClinChoice was established in 1995 and is based in Fort Washington, United States. As a contract research organization, focus is placed on data management, regulatory affairs, and consulting services within the pharmaceutical and biotechnology industries. Support is offered for clinical trial operations, compliance requirements, and strategic advisory needs across global markets. Co-founders include John D. Balian as CEO and Xin Ke.
ClinChoice's top competitors include Emmes, Syneos Health and Veristat.
ClinChoice offers Clinical Development, Post-Marketing Services, and Regulatory Affairs.
ClinChoice has made 2 acquisitions, including CROMSOURCE, and CSI Medical Research.
ClinChoice has 6 investors. Key investors include Goldman Sachs, Taikang Insurance Group, Legend Capital, Sherpa Healthcare Partners, and Lilly Asia Ventures.